Abstract
Patients with otorhinopharyngolaryngological infections were treated with 750 mg of ABPC given in three divided doses, either alone or with 3 capsules of Neuer, for 4 or more days. The patients were observed for development of gastrointestinal dis- orders including loss of appetite, nausea, vomiting, gastric distress, loose stool and tarry stool.
The overall incidence of these disorders was considerably lower in patients who were concomitantly given Neuer (11.7 e. 6 in 51) than in patients given ABPC alone (26.9%, i. e. 14 in 52)
